CMAB-808

N/A

Report date: 2023/03/04 19:34:05

Base Information

Drug NameCMAB-808
Drug Alias NameCMAB-808
ClassificationBiologics > Protein drugs > Immunoglobulin > Antibody > Monoclonal antibody > Chimeric monoclonal antibody
Mechanisms of ActionTumor necrosis factor α inhibitors
TargetsTumor necrosis factor α
Therapy Area/IndicationsN/A
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryMainland China
CombinationsNo
Global Highest StatusIND
Highest Status in ChinaIND
Originator CompaniesYuehai Baiao Pharmaceutical (Shaoxing) Co Ltd
China Registration ClassN/A

Develop Information

Active CompaniesYuehai Baiao Pharmaceutical (Shaoxing) Co Ltd
Inactive CompaniesN/A
Active IndicationsN/A
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A